INOVIO PHARMACEUTICALS, INC. Defined Contribution Plan, Cost
INOVIO PHARMACEUTICALS, INC. (INO) reported Defined Contribution Plan, Cost of $1.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2025 was $1.10M, a 14.46% increase from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2024 was $961.00K, a 31.36% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2023 was $1.40M, a 22.22% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2022 was $1.80M, a 20.00% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-03-12 |
| 2024-12-31 | $961.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $1.40M 10-K · filed 2025-03-18 |
| 2022-12-31 | $1.80M 10-K · filed 2024-03-06 |
| 2021-12-31 | $1.50M 10-K · filed 2024-03-06 |
| 2020-12-31 | $1.10M 10-K · filed 2023-03-01 |
| 2019-12-31 | $1.20M 10-K · filed 2022-03-01 |
| 2018-12-31 | $1.20M 10-K · filed 2021-03-01 |
| 2017-12-31 | $822.00K 10-K · filed 2020-03-12 |
| 2016-12-31 | $496.00K 10-K · filed 2019-03-12 |
| 2015-12-31 | $328.00K 10-K · filed 2018-03-14 |
| 2014-12-31 | $275.00K 10-K · filed 2017-03-15 |
| 2013-12-31 | $196.00K 10-K · filed 2016-03-14 |
| 2012-12-31 | $170.00K 10-K · filed 2015-03-16 |
| 2011-12-31 | $134.00K 10-K · filed 2014-03-17 |
| 2010-12-31 | $103.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |